In patients previously diagnosed with metastatic NSCLC who were found to be negative for EGFR and anaplastic lymphoma kinase (ALK) variants using traditional single-gene testing, 17.4% carried at least one EGFR or ALK variant, as outlined by NGS [22]. Here, ALK is linked to non-small cell lung carcinoma.